Insights

Strategic funding model CinRx combines financing with asset development, offering a hub-and-spoke model that accelerates portfolio progress. This positions the company as a potential partner for co-development, licensing, or investment-led collaborations to advance assets efficiently.

Portfolio breadth A diverse portfolio targeting metabolic, gastrointestinal, and oncology areas creates multiple entry points for partnerships across indications. Business development can pursue asset-by-asset licensing, strategic alliances, or milestone-driven collaborations.

Recent capital infusion A recent $73M financing round signals strong investor confidence and capacity to fund new biotech ventures. This presents opportunities for co-investment, staged financing discussions, or collaboration on expanding the portfolio pipeline.

Public market readiness Went public in 2022, indicating mature governance and exit pathways. Potential sales avenues include licensing deals, joint ventures, or strategic exits aligned with CinRx’s objective to maximize patient impact and value realization.

Small team leverage With 11-50 employees, CinRx seeks efficiency through strategic CRO partnerships and centralized operations. This openness to external collaboration suggests favorable terms for CRO-led development programs, sponsored research, and quick-to-market partnerships.

Similar companies to CinRx Pharma

CinRx Pharma Tech Stack

CinRx Pharma uses 8 technology products and services including RSS, WordPress, WooCommerce, and more. Explore CinRx Pharma's tech stack below.

  • RSS
    Content Management System
  • Content Management System
  • E-commerce
  • Lenis
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Platform As A Service
  • Max Mega Menu
    Widgets

CinRx Pharma's Email Address Formats

CinRx Pharma uses at least 3 email formats:
CinRx Pharma Email FormatsExamplePercentage
FLast@cinrx.comJDoe@cinrx.com
92%
LastFirst@cinrx.comDoeJohn@cinrx.com
4%
F.Last@cinrx.comJ.Doe@cinrx.com
4%

Frequently Asked Questions

What is CinRx Pharma's official website and social media links?

Minus sign iconPlus sign icon
CinRx Pharma's official website is cinrx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does CinRx Pharma generate?

Minus sign iconPlus sign icon
As of September 2026, CinRx Pharma's annual revenue is estimated to be $10M - $25M.

What is CinRx Pharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
CinRx Pharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CinRx Pharma have currently?

Minus sign iconPlus sign icon
As of September 2026, CinRx Pharma has approximately 16 employees across 3 continents, including North America, Asia and South America. Key team members include Senior Director, Cmc: D. L. and Autor De Ficción: M. T. Explore CinRx Pharma's employee directory with LeadIQ.

What industry does CinRx Pharma belong to?

Minus sign iconPlus sign icon
CinRx Pharma operates in the Biotechnology Research industry.

What technology does CinRx Pharma use?

Minus sign iconPlus sign icon
CinRx Pharma's tech stack includes RSS, WordPress, WooCommerce, Microsoft 365, Lenis, Underscore.js, Vercel and Max Mega Menu.

What is CinRx Pharma's email format?

Minus sign iconPlus sign icon
CinRx Pharma's email format typically follows the pattern of FLast@cinrx.com. Find more CinRx Pharma email formats with LeadIQ.

How much funding has CinRx Pharma raised to date?

Minus sign iconPlus sign icon
As of September 2026, CinRx Pharma has raised $111M in funding. The last funding round occurred on May 30, 2024 for $73M.

When was CinRx Pharma founded?

Minus sign iconPlus sign icon
CinRx Pharma was founded in 2015.
CinRx Pharma logo

CinRx Pharma

Biotechnology ResearchOhio, United States11-50 Employees

CinRx Pharma is a biotechnology company focused on advancing a diverse portfolio of therapeutic candidates through a centralized, hub-and-spoke development model. By combining financing with streamlined progression of medicines, CinRx leverages its core infrastructure and operating team to shepherd assets from discovery toward clinical development, targeting unmet needs in metabolic, gastrointestinal, and oncology areas. The company emphasizes an asset selection process that is not tied to a single therapeutic area and collaborates with a strategic contract research organization to accelerate development, drawing on insights from a broad set of programs.
Based in Cincinnati, Ohio, CinRx operates within the biotechnology research industry, positioning itself as a facilitator that identifies promising drugs and moves them through development with the aim of creating value for potential licensing deals, joint ventures, or future exits. Its approach is to fund and manage a portfolio of therapeutic candidates, using centralized governance to coordinate progression across diverse medical areas while maintaining a focus on improving patients’ quality of life.

Section iconCompany Overview

Website
cinrx.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $111M

    CinRx Pharma has raised a total of $111M of funding over 3 rounds. Their latest funding round was raised on May 30, 2024 in the amount of $73M as a Series B.

  • $10M - $25M

    CinRx Pharma's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.